Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hysteroscopic Management vs Hormonal Treatment for Cesarean Scar Defect
NCT06529952Completed
- Sponsor
- Alexandria University
- Start
- Feb 2022
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Randomised, double-blind trial (3 arms), sponsored by Alexandria University. Primary endpoints: presence or absence of intermenstrual spotting at 6 months, presence or absence of postcoital bleeding at 6 months and 1 more. Started Feb 2022; status: completed.
Beyond the preview
Go deeper on NCT06529952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06529952.